Docusign Envelope ID: D6116EA2-B1A0-476A-B593-9172DF9F7847
Trustees' Annual Report for the period Period start date Period end date T Day Month Year Day Month Year From 01 Nov 2024 o 31 Oct 2025
Section A Reference and administration details
Charity name Allez Charity Events Other names charity is known by Fireflies Europe Registered charity number (if any) 1164828 Charity's principal address Mount Pleasant Studios 51-53 Mount Pleasant London Postcode WC1X 0AE
Names of the charity trustees who manage the charity
Trustee name
Office (if any)
Dates acted if not for whole year
Name of person (or body) entitled to appoint trustee (if any)
-
1 Paul Adler
-
2[Richard ] Lewisohn
-
3 Chris Page
-
4 John Mawhood
-
5[Timothy McCoy-] Page
-
6 John Taylor
-
7 Alan Burns
-
8
March 2012
TAR
1
Docusign Envelope ID: D6116EA2-B1A0-476A-B593-9172DF9F7847
Names of the trustees for the charity, if any, (for example, any custodian trustees)
Name Dates acted if not for whole year
Names and addresses of advisers (Optional information)
Type of adviser Name Address
Name of chief executive or names of senior staff members (Optional information)
Section B Structure, governance and management
Description of the charity’s trusts
Type of governing document Constitution dated 23 October 2015 (eg. trust deed, constitution)
How the charity is constituted Charitable Incorporated Organisation (eg. trust, association, company)
Trustee selection methods Appointed by agreement of the existing trustees, for a term of between (eg. appointed by, elected by) two and four years, subject to any extraordinary resolution of the trustees.
Additional governance issues (Optional information)
March 2012
TAR
2
Docusign Envelope ID: D6116EA2-B1A0-476A-B593-9172DF9F7847
In selecting individuals for appointment as charity trustees, the existing You may choose to include charity trustees have regard to the skills, knowledge and experience additional information, where needed for the effective administration of the CIO and will enhance this relevant, about: through induction and training where appropriate.
-
policies and procedures adopted for the induction and training of trustees;
-
the charity’s organisational structure and any wider network with which the charity works;
-
relationship with any related parties;
-
trustees’ consideration of major risks and the system and procedures to manage them.
Section C Objectives and activities
Summary of the objects of the charity set out in its governing document
The object of the CIO is to advance such charitable purposes (according to the law of England and Wales) as the trustees see fit from time to time in particular but not limited to the advancement of research into potential cures and treatments of blood cancers, for the public benefit of those persons currently suffering from these diseases, and those who may in the future be diagnosed with these diseases. The CIO will in particular but not exclusively organise fundraising events, and make donations or grants in furtherance of its object.
March 2012
TAR
3
Docusign Envelope ID: D6116EA2-B1A0-476A-B593-9172DF9F7847
The trustees have had regard to the guidance issued by the Charity Commission on public benefit. The CIO makes one or more donations to carefully selected organisations, consistent with its object.
Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)
Research into potential cures and treatments for blood cancer provides a clear public benefit in reducing the risk of contracting diseases such as Leukaemia and Lymphoma, and increasing the possibility for patients to make a successful recovery. There are several renowned organisations operating in the UK, which have demonstrated through their research and clinical practice, substantially positive outcomes for patients and have communicated their know-how more widely, through peerreviewed publications and conferences. They participate in important initiatives, which promote pan-European and other international collaboration in research and clinical excellence in treating blood cancers.
The section of the UK public who will benefit most from the work of our CIO is those persons who are currently suffering from a blood cancer, and those who may in the future be diagnosed with a blood-cancer related disease.
Additional details of objectives and activities (Optional information)
The trustees follow a thorough process to identify suitable recipient(s) of the funds that we raise: typically either another charity, which closely aligns with our object (ie. focused on cancer research) or for example a renowned research team associated with a hospital cancer treatment ward.
You may choose to include further statements, where relevant, about:
-
policy on grantmaking;
-
policy programme related investment;
-
contribution made by volunteers.
We go through both a vetting process, including visit(s) to potential recipient(s) where appropriate, and a verification process (postdonation) to receive feedback on how our donated funds have been used.
There is an annual review of the effectiveness of these processes and corrective steps are taken where necessary to ensure that the funds we have raised are used according to our declared object. We continue to communicate with Professor Jane Apperley, the principal of Imperial Health Charity (Blood Fund) and through the discussions have been able to review and verify the satisfactory use of the grant made during 2024 and look ahead to plans for 2025.
The CIO is entirely organised and staffed by volunteers, to whom we are very grateful. The trustees and others donate the use of premises and facilities required for our fundraising operations.
March 2012
TAR
4
Docusign Envelope ID: D6116EA2-B1A0-476A-B593-9172DF9F7847
Section D Achievements and performance
Summary of the main achievements of the charity during the year
A formal grant-making policy is yet to be developed, but would be based on the principles explained in the preceding paragraphs. The trustees remain at the heart of the decision-making process and other beneficiaries may be considered for future years.
Fundraising events will be restarted in 2026 - it is expected that this will make a substantial improvement to our effectiveness - and detail plans are being developed. Insurance cover primarily relates to the cycling training (see below), which according to our assessment is the main risk. The trustees act as the main officers of the Fireflies Cycling Club, which is unincorporated.
The CIO was able to attract 25 members to join the “Fireflies Cycling Club” which organises training for novice and improver cyclists enabling them to participate successfully and safely in endurance cycling events.
Meetings of the trustees were held both face-to-face and virtually, including with sister groups around the world, which have similar objectives.
March 2012
TAR
5
Docusign Envelope ID: D6116EA2-B1A0-476A-B593-9172DF9F7847
Section E Financial review
The CIO aims to maintain around 12-18 months’ worth of expenditure in Brief statement of the charity’s the current account, in order to facilitate investment in future fundraising policy on reserves activities without assuming undue risk.
Details of any funds materially in deficit
Further financial review details (Optional information)
You may choose to include additional information, where relevant about:
-
the charity’s principal sources of funds (including any fundraising);
-
how expenditure has supported the key objectives of the charity;
-
investment policy and objectives including any ethical investment policy adopted.
Section F Other optional information
March 2012
TAR
6
Docusign Envelope ID: D6116EA2-B1A0-476A-B593-9172DF9F7847
Section G Declaration
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
----- Start of picture text -----
Signature(s)
Full name(s) Paul Adler Chris Page
Position (eg Secretary, Trustee Trustee
Chair, etc)
Date 1/12/2026
----- End of picture text -----
March 2012
TAR
7
Docusign Envelope ID: 314FA55B-5955-4479-AB0B-F574938DF554
| Allez Charity Events | Allez Charity Events | Allez Charity Events | Allez Charity Events | Allez Charity Events | 1164828 | 1164828 | CC16a | ||
|---|---|---|---|---|---|---|---|---|---|
| Receipts andpayments accounts | |||||||||
| For the period from |
01/11/2024 | To | 31/10/2025 | ||||||
| Section A Receipts and payments | |||||||||
| Unrestricted funds |
Restricted funds | Endowment funds |
Total funds | Last year | |||||
| to the nearest £ | to the nearest £ | to the nearest £ | to the nearest £ | to the nearest £ | |||||
| A1 Receipts | |||||||||
| Charitable Donations | - | - | - | - | - | ||||
| MembershipSubscriptions | 375 | - | - | 375 | 315 | ||||
| Sales of Clothing (for Fundraising) | - | - | - | - | |||||
| SpinningClass Income | 1 355 | - | - | 1 355 | - | ||||
| Incidental Sales at FundraisingEvents | - | - | - | - | |||||
| Trustee Loans(Repayable) | - | - | - | - | |||||
| HMRC Gift Aid Refund | - | - | - | - | |||||
| - | - | - | - | ||||||
| - | - | - | - | ||||||
| Sub total _(Gross income for AR) _ | 1 730 | - | - | 1 730 | 315 | ||||
| ~~A2 Asset and investment sales, (see~~ table). |
|||||||||
| - | |||||||||
| - | |||||||||
| Sub total | - | - | - | - | - | ||||
| Total receipts | 1 730 | - | - | 1 730 | 315 | ||||
| A3 Payments | |||||||||
Accounting & Website Software |
173 | - | - | 173 | 215 | ||||
| Bank Fees | 8 | - | - | 8 | 10 | ||||
| Charitable Donations - Imperial Healthcare/Blood Fund |
- | - | - | - | 300 | ||||
| Payments to Clothing Suppliers | - | - | - | - | - | ||||
| Insurance | - | - | - | - | 74 | ||||
| Incidental Costs of Fundraising Events | - | - | - | - | - | ||||
| SpinningClass Cost | 1 344 | - | - | 1 344 | - | ||||
| Subscriptions | 81 | - | - | 81 | - | ||||
| Sundry Postage, Courier, Stationery | - | - | - | - | - | ||||
| - | - | - | - | - | |||||
| **Sub total ** | 1 606 | - | - | 1 606 | 599 | ||||
| A4 Asset and investment purchases, (see table) |
|||||||||
| - | - | - | - | ||||||
| - | - | - | - | ||||||
| **Sub total ** | - | - | - | - | - | ||||
| Totalpayments | 1 606 | - | - | 1 606 | 599 | ||||
| Net of receipts/(payments) | 124 | - | - | 124 | (284) | ||||
| A5 Transfers between funds | - | - | - | - | |||||
| A6 Cash funds last year end | 2 114 | - | - | 2 114 | 2 398 | ||||
| Cash funds thisyear end | 2 239 | - | - | 2 239 | 2 114 | ||||
1
CCXX R1 accounts (SS)
19/11/2023
Docusign Envelope ID: 314FA55B-5955-4479-AB0B-F574938DF554
| Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Section B Statement of assets and liabilities at the end of the period Categories Unrestricted funds Restricted funds Details |
Endowment funds |
|---|---|---|---|---|---|---|---|---|---|
| Categories | |||||||||
| to nearest £ | to nearest £ | to nearest £ | |||||||
| B1 Cash funds | Balance at Barclays Bank | 2 239 | - | - | |||||
| - | - | - | |||||||
| - | - | - | |||||||
| Total cash funds | 2 239 | - | - | ||||||
| (agree balances with receipts and payments account(s)) |
OK Unrestricted funds |
OK Endowment funds |
|||||||
| Details | to nearest £ | to nearest £ | to nearest £ | ||||||
| B2 Other monetary assets | - | - | - | ||||||
| - | - | - | |||||||
| - | - | - | |||||||
| - | - | - | |||||||
| - | - | - | |||||||
| - | - | - | |||||||
| Details | Fund to which asset belongs |
Cost (optional) | Current value (optional) |
||||||
| B3 Investment assets | - | - | |||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| Details | Fund to which asset belongs |
Cost (optional) | Current value (optional) |
||||||
| B4 Assets retained for the charity’s own use |
|||||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| - | - | ||||||||
| Details | Fund to which liability relates |
Amount due (optional) |
When due (optional) |
||||||
| B5 Liabilities | - | ||||||||
| - | |||||||||
| - | |||||||||
| - | |||||||||
| - | |||||||||
| Signed by one or two trustees on behalf of all the trustees |
Signature |
Print Name | Date of approval | ||||||
| Paul Adler | 1/13/2026 | ||||||||
| Chris Page | 1/13/2026 | ||||||||
2
CCXX R2 accounts (SS)
19/11/2023